Epidemiology and etiology of gliomas

By H. Ohgaki, P. Kleihues. Acta Neuropathologica, 2005

1,299 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. (2005, background): “In particular, children treated with X-irradiation for acute lymphoblastic leukemia show a significantly elevated risk of developing gliomas and primitive neuroectodermal tumors (PNET), often within 10 years after therapy (21, 53, 54).”
An integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR and NF1 (2010, background): “Patients with GBM have a uniformly poor prognosis, with a median survival of one year (Ohgaki and Kleihues, 2005); thus, advances on all scientific and clinical fronts are needed.”
Glioblastoma Multiforme: A Review of its Epidemiology and Pathogenesis through Clinical Presentation and Treatment (2017, background): “The ratio of GBM incidence is higher in men as compares to women (Ohgaki and Kleihues, 2005; Thakkar et al., 2014).”
The Definition of Primary and Secondary Glioblastoma (2012, background): “The combined incidence rates of low-grade and anaplastic astrocytomas are approximately twice as high as that of clinically diagnosed secondary glioblastoma or IDH1 glioblastoma (30, 64, 69).”
Genetics of adult glioma. (2012, background): “This suggests a possible role of immunological factors in the development of glioma, although the specific mechanism is poorly understood at this time (6,9).”